Reactive oxygen species (ROS) generated endogenously or from exogenous sources produce mutagenic DNA lesions. If not repaired, these lesions could lead to genomic instability and, potentially, to cancer development. NEIL2 (EC 4.2.99.18), a mammalian base excision repair (BER) protein and ortholog of the bacterial Fpg/Nei, excises oxidized DNA lesions from bubble or single-stranded structures, suggesting its involvement in transcriptioncoupled DNA repair. Perturbation in NEIL2 expression may, therefore, significantly impact BER capacity and promote genomic instability. To characterize the genetic and environmental factors regulating NEIL2 gene expression, we mapped the human NEIL2 transcriptional start site and partially characterized the promoter region of the gene using a luciferase reporter assay. We identified a strong positive regulatory region from nucleotide 2206 to 190 and found that expression from this region was contingent on its being isolated from an adjacent strong negative regulatory region located downstream (149 to 1710 bp), suggesting that NEIL2 transcription is influenced by both these regions. We also found that oxidative stress, induced by glucose oxidase treatment, reduced the positive regulatory region expression levels, suggesting that ROS may play a significant role in regulating NEIL2 transcription. In an initial attempt to characterize the underlying mechanisms, we used in silico analysis to identify putative cis-acting binding sites for ROS-responsive transcription factors within this region and then used site-directed mutagenesis to investigate their role. A single-base change in the region encompassing nucleotides 2206 to 190 abolished the effect of oxidative stress that was observed in the absence of the mutation. Our study is the first to provide an initial partial characterization of the NEIL2 promoter and opens the door for future research aimed at understanding the role of genetic and environmental factors in regulating NEIL2 expression.
Introduction
The human genome is constantly exposed to reactive oxygen species (ROS) which induce oxidative DNA lesions that may lead to mutations, genomic instability and, potentially, to the development of cancer (1, 2) . The DNA base excision repair (BER) pathway includes several proteins that function in a stepwise manner to repair these DNA lesions (2, 3) . The importance of maintaining the integrity of this pathway has been demonstrated by many epidemiological studies. For example, changes in the activity or protein structure of several BER enzymes, including 8-oxoguanine-DNA glycosylase (OGG1) and apurinic/apyrimidinic endonuclease, have been associated with elevated cancer risk (4) . In addition, polymorphisms of the XRCC1 and ADPRT genes, which code for other important BER proteins, were associated with increased genetic damage and increased cancer risk (1, (5) (6) (7) .
The first step in the BER pathway is the recognition and removal of the damaged DNA base, usually by a glycosylase (3) . In mammals, several BER glycosylases have been identified, including the monofunctional glycosylases endonuclease III homolog 1 and OGG1, and the newly discovered NEIL1 and NEIL2 proteins. The latter two belong to the Fpg/Nei family of BER enzymes (8) (9) (10) (11) (12) . Recent studies have shown unique important properties of NEIL2 that set it apart from other BER glycosylases. For example, NEIL2 is active throughout the cell cycle, but its activity is enhanced in the presence of oxidative stress, further emphasizing its potential importance in removing oxidative DNA damage (8) (9) (10) (11) (12) (13) (14) . Furthermore, there is a growing evidence suggesting that NEIL2 is involved in transcriptioncoupled DNA repair, which may have important health implications since the repair of oxidized bases from active sequences during transcription is critical to normal mRNA processing and stability (15) . As such, NEIL2 may play a substantial role in maintaining genomic stability not only in highly proliferating cells but also in non-dividing cells that remain transcriptionally active, such as nerve cells (16) . Therefore, factors affecting the level of expression of NEIL2 protein, or those that affect its structure and function, may lead to diverse and serious health consequences.
With the long-term goal of characterizing the genetic and the environmental factors involved in the regulation of NEIL2 expression, in this study, we partially characterized the promoter of the NEIL2 gene after mapping its transcriptional start site. We then identified a positive regulatory region within the NEIL2 promoter that was responsive to oxidative stress.
Twenty-four hours prior to transfection, cells were harvested from the flasks, counted and seeded in 6-well plates at a concentration of 3.5 Â 10 5 cells per well.
Mapping of the NEIL2 transcriptional start site and in silico analysis for the identification of putative cis-acting binding sites in the promoter region The FirstChoice RLM-RACE primer extension kit (Ambion, Inc., Austin, TX) was used to identify the transcriptional start site. Briefly, total RNA was isolated from MRC-5 cells and a 10 lg of the total RNA was treated with calf intestine alkaline phosphatase and then treated with tobacco acid pyrophosphatase to specifically modify the full-length mRNA for adapter ligation. The 5# RACE adapter (included with the primer extension kit) was ligated to the 5# end of the full-length mRNA, which provided a template for primer extension during the subsequent reverse transcription and polymerase chain reaction (PCR) amplifications. In the first reaction, the 5# RACE outer primer (included with the kit) was used in combination with the NEIL2 gene-specific primers (RACE1, 5#-TCTTCCGAGTGCCCGAGGTG-3# and RACE2, 5#-GGGGTTGTCTCCGCCGTTC-3#) that were designed based on GenBank mRNA (NM_145043) sequence data. A second PCR reaction was used to amplify the region using the same gene-specific primers and the 5# RACE inner primer (included with the extension kit). The products of this latter reaction were sequence verified using the ABI Prism 3100 Sequence Detection System (Applied Biosystems, Foster City, CA) and BLASTn software (National Center for Biotechnology Information).
Following the identification of the transcriptional start site, the transcription element search system (TESS, University of Pennsylvania), which allows the in silico identification of functional cis-acting binding sites within the DNA strand (17) , was subsequently used to search for putative cis elements located within the proximity of the transcriptional start site. The TESS analysis was performed using the default basic and expert parameters. An initial search for all transcription factors was conducted, which was later restricted to ROS-responsive factors.
Cloning of the NEIL2 5# upstream region into luciferase reporter vectors
The 5# gene region of NEIL2 was isolated from genomic DNA through PCR. We used primers that were specifically designed to amplify the regions of interest (Table I ). The resulting fragments were then cloned into the pCR2.1 vector, using the TA Cloning Kit (Invitrogen, Inc., Carlsbad, CA) and then subcloned into the KpnI/EcoRI restriction sites in the promoter-less luciferase expression plasmid, pGL3-Basic (Promega, Inc., Madison, WI) to create the three plasmids pSTEP1, pSTEP2 and p1200. The construct pSTEP3 was created by cloning a 661-bp fragment of the region from þ49 to þ710 into the BglII site of the pGL3-Basic vector (see Figure 1 ).
Sub-clone constructs of the p1200 and pSTEP3 fragments
In addition to the constructs described above, three fragments were amplified from the p1200 construct (see Figure 1 ) using the primers shown in Table I . The fragment encompassing the 5# region of the p1200 insert (from À1161 to À661) was used to create the p1200A construct. The central fragment (from À702 to À104) was used to create the p1200B construct. The 3# region (from À206 to þ90) was used to create the p1200C construct.
To evaluate the characteristics of the pSTEP3 fragment, we cloned this fragment into a pGL-control vector containing the strong, ubiquitous simian virus 40 promoter (pSV40). The pSV40-STEP3 construct was created by ligating the BglII fragment. The integrity of the cloned fragments was verified by direct sequencing. Plasmid DNA used for transfections was isolated using the Qiagen EndoFree Maxi prep (Qiagen, Inc., Valencia, CA). The stock DNA extract was diluted in endotoxin-free water to a final concentration of 1 lg/ll prior to transfection. In order to ensure plasmid integrity, all plasmid preparations were performed 3 days prior to transfection. 
Schematic presentation of the NEIL2 gene and the relative locations of the promoter fragments isolated, cloned and sub-cloned into luciferase reporter vectors. The identified transcriptional start site is designated as þ1.
Site-directed mutagenesis and luciferase expression constructs
Using the p1200C as a template, we used the Quickchange Site-Directed Mutagenesis Kit (Stratagene, Inc., La Jolla, CA) to introduce a single-base change at a location 104 bp 5# of the transcriptional start site (denoted as À104 G to C). The PCR primer set 5#-GCCTCCACCTACAGGCGCGTCCCC-TAAGGGG-3# and 5#-CCCCTTAGGGGACGCGCCTGTAGGTGGAGGC-3# were used in this process. This single-base change (bold and underlined) was predicted by TESS analysis to abolish the binding sites for the nuclear factor kappa-light-chain-enhancer of activated B cells (NFjB) and Sp-1 transcription factors ( Figure 2 ). Although extreme care was used to achieve optimal and reproducible experimental conditions, we found that luciferase expression varied from Factors regulating NEIL2 expression experiment to experiment based on cell passage number. Each experiment was therefore normalized to its own internal control and was performed on cells from the same passage.
Response of the p1200C construct to oxidative stress MRC-5 cells were transfected with the p1200C construct (the fragment from À206 to þ90 bp) and treated with the cellular oxidant glucose oxidase (GO) in presence of flavin adenine dinucleotide acquired from Roche Applied Science, Inc. (Basel, Switzerland) at a final concentration of 100 ng/ml. GO is a strong cellular hydrogen peroxide (H 2 O 2 ) generator that creates an environment conducive to dynamic oxidative DNA damage, and at this concentration, it was shown to increase intracellular ROS in cultured cells by 2.4-fold after 1 h of treatment (16) . Prior to treatment, cultures were allowed to recover for 24 h (after transfection) in fresh medium. Cells were treated with GO and luciferase expression levels determined at 1, 6 and 12 h after treatment. The experimental conditions used did not affect cell viability, as determined by trypan blue exclusion.
Statistical analysis
The Student's t-test and analysis of variance were used, when appropriate, to compare the means between treatment groups. A two-sided P , 0.05 was considered statistically significant. All statistical analyses were performed using NCSS 2004 (Kaysville, UT).
Results
Mapping of the NEIL2 transcriptional start site and identification of cis elements in the NEIL2 promoter region Our results indicate that the guanine residue at location 11664692G on chromosome 8 is the transcriptional start site (designated as þ1 in Figures 1 and 2 ). Using the TESS software (17), we were also able to identify, in silico, several potential binding sites for transcription factors in this region, including those for NFjB, a cAMP response element-binding protein and an activator protein 1 site (a heterodimer formed from C-jun and C-Fos) ( Figure 2 ). The analysis of the sequence surrounding the transcriptional start site suggests that the NEIL2 gene is driven by a GC-rich, TATA-less promoter.
Partial characterization of the NEIL2 promoter region
To characterize the promoter of the NEIL2 gene, we isolated regions of DNA surrounding the identified transcriptional start site. These isolated DNA fragments were then cloned into luciferase reporter vectors and subsequently tested for their ability to drive luciferase expression in vitro. Relative luciferase expression from each construct was measured and then normalized to the co-transfected Renilla plasmid. As shown in Figure 3A , the largest construct of the NEIL2 promoter fragment pSTEP1 (the fragment from À1161 to þ710 bp) did not drive expression. We therefore designed the p1200 construct (from À1161 to þ90 bp), which contained the first 1251 of the À1161 to þ710-bp fragment, including the transcription start site. This was equivalent to deleting the pSTEP3 fragment (þ49 to þ710 bp) located in the À1161 to þ710 fragment. The p1200 construct showed a 5-fold higher expression level compared to the pSTEP1, suggesting that it contained positive regulatory elements ( Figure 3B ). Furthermore, because the À1161 to þ90 fragment did not contain the þ49 to þ710 fragment, we hypothesized that the þ49 to þ710 region contained negative regulatory elements that repressed the induction of NEIL2 expression observed with the pSTEP1 and pSTEP2 constructs.
To characterize the repressive characteristics of the þ49 to þ710 fragment (pSTEP3), we cloned it into a pGL control vector containing the SV40 promoter ( Figure 4A ). Inserting the þ49 to þ710 fragment proximal to the SV40 promoter (pSV40-STEP3) resulted in a 91% decrease in SV40-driven luciferase expression ( Figure 4B ).
We further characterized key regions responsible for positive regulation of the NEIL2 gene by sub-cloning segments of the À1161 to þ90 fragment (p1200) into three constructs (p1200A, p1200B and p1200C; Figure 5A ). While the relative promoter activity of the p1200C construct (containing the fragment from À206 to þ90 bp and the transcriptional start site) was comparable to the relative promoter activity of the À1161 to þ90 fragment (p1200), the relative promoter activity of the p1200A construct (the fragment from À1161 to À661 bp) was 5-fold lower than that of the p1200C (P , 0.01). In addition, the promoter activity of the fragment from À702 to À104 bp (p1200B) was 3-fold lower than that of p1200C (P , 0.01; Figure 5B ).
Response of the p1200C construct (À206 to þ90 fragment) to oxidative stress Because the fragment from À206 to þ90 bp (p1200C) drove the highest level of luciferase expression, we examined the response of this fragment to oxidative stress induced by GO. The À206 to þ90 fragment responded dramatically to GO treatment, with a significant transient decrease in luciferase expression at 1 h that persisted for up to 6 h after treatment (40% decrease; P , 0.01). At 12 h, expression completely recovered to the same level as the untreated (Figure 6) .
In silico analysis of the p1200C plasmid indicated the presence of a genomic sequence of a potential putative NFjB/ Sp-1 site. Because both NFjB and Sp-1 transcriptional regulating proteins are known to be activated by ROS, perturbation of this site might affect the response to oxidative stress (18) (19) (20) . Our data indicate that cells transfected with the p1200C plasmid containing a À104 G to C mutation within the sequence of the potential NFjB/Sp-1-binding site elicited a different response compared to cells transfected with the wild-type p1200C plasmid. In cells transfected with the mutated plasmid, there was no change in expression level observed following exposure to GO for 1 h (Figure 7) .
Discussion
This study is the first to provide an initial partial characterization of the NEIL2 promoter and the first to identify the transcriptional start site and important genetic factors regulating NEIL2 expression. Evaluation of the expression activities of several fragments of the promoter region revealed that the 1871-bp fragment from À1161 to þ710 (pSTEP1 construct) did not drive expression in MRC-5 cells, even though it contained the transcriptional start site as well as several putative transcriptional element-binding sites. These findings suggest that this fragment may contain negative regulatory regions that suppress expression. In fact, sub-cloning of this fragment demonstrated that it contained both positive and negative regulatory regions.
The results from our sub-cloning studies indicate that the þ49 to þ710 fragment did not drive luciferase expression in the pSTEP3 construct. A possible explanation to this finding could be that this fragment lacks the transcriptional start site. However, when this fragment was placed in front of the fulllength SV40 promoter, which contained a start site, it reduced the SV40-driven luciferase expression by 91%, strongly suggesting that it contains repression elements that may negatively impact NEIL2 gene expression. Further support to this conclusion stems from the fact that this fragment was common to both pSTEP1 and pSTEP2, both of which contained the start site, but still did not drive luciferase expression. In addition, the SV40 promoter is commonly used in the pGL3 control vector as a positive transfection control because it promotes strong reporter gene expression in various mammalian cell types (21) . As such, repressing its expression would, presumably, require robust repression elements. Our Factors regulating NEIL2 expression results, therefore, strongly suggest that this region of the NEIL2 promoter retains strong repression motifs that regulate basal NEIL2 gene expression.
Our study showed that the fragment from À1161 to þ90 bp (p1200) drove substantial luciferase expression, suggesting that it is likely to contain positive regulatory elements. Our in silico TESS analysis suggested the presence of putative cis-binding sites for various transcription factors within the À1161 to þ90 fragment, particularly within the À206 to þ90 region. The results from the experiments in which we used the three constructs (p1200A, p1200B and p1200C), each containing different regions of the À1161 to þ90 insert (Figure 1) , clearly indicate that the À206 to þ90 fragment contained essential positive regulatory elements. Our results indicate that an indepth examination of this region is needed to identify the specific elements responsible for driving expression from this construct.
Because the NEIL2 protein is involved in the repair of oxidative DNA damage, we hypothesized that NEIL2 gene expression would be responsive to ROS. Our results indicate that GO treatment of MRC-5 cells transiently transfected with the p1200C plasmid (the À206 to þ90 fragment) was associated with down-regulation of expression. Transcriptional response to ROS is diverse and may include induction or repression of gene expression (20, 22, 23) . For example, in some studies, ROS were shown to act as a cellular messenger that activates the transcription of some DNA repair genes (24) , while in other studies ROS had no effect on expression levels of other DNA repair genes, including XRCC1, XRCC5 and ERCC5 (25) . Consistent with our findings, it has been also shown that ROS can down-regulate gene transcription. For example, ROS have been shown to down-regulate the transcription of OGG1 (another BER protein), cytokines, tumor necrosis factor alpha as well as pro-inflammatory genes (20, 22, 23) . Several motifs in the NEIL2 promoter that bind transcription factors could negatively be impacted in presence of oxidative stress (20) . For example, the transactivation by the Sp-1 factor, the E26 transformation-specific (ETS) transcription factor and the upstream stimulatory factor (USF) are known to be inhibited in the presence of ROS (20) . It is interesting to note that our TESS in silico analysis suggests the presence of putative USF-binding sites and several putative SP-1-binding sites in the À206 to þ90 fragment (p1200C) located upstream but close to the transcriptional start site. A plausible explanation to our findings with the p1200C construct could, therefore, be that the oxidative conditions induced by GO resulted in inhibition of binding of transcriptional proteins, such as Sp-1, USF or ETS, to their respective sites on the DNA in a similar manner as discussed above, which resulted in reduced luciferase expression in cells transfected with the p1200C construct.
The results from our in silico analysis also revealed the potential presence of a dual motif for both a Sp-1 and NFjBbinding protein in the À206 to þ90 fragment ( Figure 2 ). Both of these transcription factors have been well characterized with respect to their role in regulating gene expression in cells under oxidative stress. Thus, our findings suggest that there could be at least two ROS-responsive transcription factors competing for binding at this site (19) . The results from our site-directed mutagenesis studies of this region indicate that introducing a mutation at this site changes the response of this regulatory region to oxidative stress. While additional studies are still needed to identify the specific factors involved in this response, our studies indicate that sequence variations in the NEIL2 promoter region can significantly alter the transcriptional response to oxidative stress.
In conclusion, our study is the first to provide an initial partial characterization of the NEIL2 promoter and opens the door for future research aimed at understanding the role of genetic and environmental factors in regulating NEIL2 expression. Our study also identifies important gaps in knowledge that need to be addressed by future studies. An important issue is the biological effect of down-regulation of NEIL2 in response to oxidative stress, given the possible importance of this protein in transcription-coupled DNA repair. In rapidly proliferating tissues, reduced NEIL2 transcription may lead to increased oxidative stress and genomic instability. In nondividing, but transcriptionally active cells, this may lead to a mutagenic cell state. 
